Brooks-Warburton Johanne, Ashton James, Dhar Anjan, Tham Tony, Allen Patrick B, Hoque Sami, Lovat Laurence B, Sebastian Shaji
Department of Clinical Pharmacology and Biological Sciences, University of Hertfordshire, Hatfield, UK.
Gastroenterology Department, Lister Hospital, Stevenage, UK.
Frontline Gastroenterol. 2021 Dec 10;13(4):325-331. doi: 10.1136/flgastro-2021-102003. eCollection 2022.
Artificial intelligence (AI) is an emerging technology predicted to have significant applications in healthcare. This review highlights AI applications that impact the patient journey in inflammatory bowel disease (IBD), from genomics to endoscopic applications in disease classification, stratification and self-monitoring to risk stratification for personalised management. We discuss the practical AI applications currently in use while giving a balanced view of concerns and pitfalls and look to the future with the potential of where AI can provide significant value to the care of the patient with IBD.
人工智能（AI）是一项新兴技术，预计将在医疗保健领域有重要应用。本综述重点介绍了影响炎症性肠病（IBD）患者就医过程的人工智能应用，从基因组学，到疾病分类、分层和自我监测中的内镜应用，再到个性化管理的风险分层。我们讨论了目前正在使用的实际人工智能应用，同时对相关问题和缺陷给出了全面的看法，并展望了人工智能在为IBD患者护理提供重大价值方面的潜力。
